down arrow

Sutro Biopharma, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US8693671021
USD
31.55
1.92 (6.48%)

Jun 22

NAS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
14.52
11.65
9.69
63.74
17.40
14.81
8.52
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
14.52
11.65
9.69
63.74
17.40
14.81
8.52
Raw Material Cost
1.28
1.62
1.90
1.90
1.90
1.87
1.80
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
9.47
9.55
9.67
9.65
9.34
8.69
7.91
Selling and Distribution Expenses
6.31
7.04
6.84
8.44
11.37
7.16
12.53
Other Expenses
2.71
2.71
3.02
2.87
4.23
6.23
5.42
Total Expenditure (Excl Depreciation)
44.14
45.30
48.59
48.67
64.87
80.07
76.44
Operating Profit (PBDIT) excl Other Income
-29.6
-33.7
-38.9
15.1
-47.5
-65.3
-67.9
Other Income
0.62
0.75
1.27
1.48
1.89
3.86
27.04
Operating Profit (PBDIT)
-27.71
-31.28
-35.73
18.45
-43.68
-59.53
-39.08
Interest
9.47
9.55
9.67
9.65
9.34
8.69
7.91
Exceptional Items
-0.04
-4.39
-9.56
-18.42
-21.04
0.00
0.00
Gross Profit (PBDT)
13.24
10.02
7.79
61.84
15.50
12.94
6.72
Depreciation
1.28
1.62
1.90
1.90
1.90
1.87
1.80
Profit Before Tax
-38.50
-46.84
-56.86
-11.52
-75.97
-70.09
-48.79
Tax
-0.01
-0.08
0.00
-0.02
0.00
2.35
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-38.48
-46.76
-56.86
-11.50
-75.97
-72.44
-48.79
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-38.48
-46.76
-56.86
-11.50
-75.97
-72.44
-48.79
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-38.48
-46.76
-56.86
-11.50
-75.97
-72.44
-48.79
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
-66.89
-132.45
-87.27
-32.11
-25.81
44.60
111.22
Earnings per share (EPS)
-2.94
-5.45
-6.7
-1.36
-9.14
-8.78
-5.95
Diluted Earnings per share
-2.94
-5.45
-6.7
-1.36
-9.14
-8.78
-5.95
Operating Profit Margin (Excl OI)
-203.91%
-288.98%
-401.33%
23.65%
-272.84%
-440.66%
-797.17%
Gross Profit Margin
-256.29%
-388.25%
-566.98%
-15.09%
-425.7%
-460.67%
-551.5%
PAT Margin
-264.99%
-401.49%
-586.58%
-18.04%
-436.62%
-489.18%
-572.62%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is -16.67% vs 33.85% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 49.34% vs -30.58% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 37.94% vs 16.79% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 2.15% vs 29.17% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Sutro Biopharma, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
14.52
0.00
14.52
Other Operating Income
0.00
0.00
0.00
Total Operating income
14.52
0.00
14.52
Raw Material Cost
1.28
0.04
1.24
3,100.00%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
9.47
0.00
9.47
Selling and Distribution Expenses
6.31
27.83
-21.52
-77.33%
Other Expenses
2.71
7.80
-5.09
-65.26%
Total Expenditure (Excl Depreciation)
44.14
105.86
-61.72
-58.30%
Operating Profit (PBDIT) excl Other Income
-29.61
-105.86
76.25
72.03%
Other Income
0.62
13.30
-12.68
-95.34%
Operating Profit (PBDIT)
-27.71
-92.52
64.81
70.05%
Interest
9.47
0.00
9.47
Exceptional Items
-0.04
0.00
-0.04
Gross Profit (PBDT)
13.24
-0.04
13.28
33,200.00%
Depreciation
1.28
0.04
1.24
3,100.00%
Profit Before Tax
-38.50
-92.56
54.06
58.41%
Tax
-0.01
0.00
-0.01
Provisions and contingencies
0
0
0.00
Profit After Tax
-38.48
-92.56
54.08
58.43%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-38.48
-92.56
54.08
58.43%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-38.48
-92.56
54.08
58.43%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
-66.89
1,409.96
-1,476.85
-104.74%
Earnings per share (EPS)
-2.94
-3.20
0.26
8.13%
Diluted Earnings per share
-2.94
-3.20
0.26
8.13%
Operating Profit Margin (Excl OI)
-203.91%
0.00%
0.00
-203.91%
Gross Profit Margin
-256.29%
0.00%
0.00
-256.29%
PAT Margin
-264.99%
0.00%
0.00
-264.99%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1.45 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 25.00% vs 19.59% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -16.67% vs 33.85% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit -3.85 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 17.74% vs 17.75% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 49.34% vs -30.58% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -2.83 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 11.56% vs 13.51% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 37.94% vs 16.79% in Mar 2025

Quarterly - Interest
Interest 0.95 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 0.00% vs -2.06% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 2.15% vs 29.17% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -203.91%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."